Physician- and patient-reported outcomes in patients with moderate plaque psoriasis treated with apremilast during routine dermatology care in Germany

被引：0

作者：

Reich, K. ^{[1
,2
]}

Fritzlar, S.

Korge, B.

Manasterski, M.

Schwichtenberg, U. ^{[3
]}

Morys, S. ^{[4
]}

Lampl, M. ^{[4
]}

Roemmler-Zehrer, J. ^{[4
]}

Gomez, Nunez N. ^{[4
]}

机构：

[1] SCIderm Res Inst, Hamburg, Germany

[2] Dermatologikum Berlin, Berlin, Germany

[3] Derma Nord Hautarztpraxen Dr med Schwichtenberg, Bremen, Germany

[4] Celgene GmbH, Munich, Germany

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2019年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P115-A

引用

页码：123 / 124

页数：2

共 50 条

[1] Physician- and Patient-Reported Outcomes in Patients With Moderate to Severe Plaque Psoriasis Treated With Apremilast During Routine Dermatology Care in Germany
Reich, Kristian
Fritzlar, Stefanie
Korge, Bernhard
Manasterski, Maria
Schwichtenberg, Uwe
Morys, Stephan
Lorenz-Baath, Katrin
Roemmler-Zehrer, Josefine
Gomez, Natalie Nunez
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 21 - 21
[2] Physician- and patient-reported outcomes for patients with plaque psoriasis treated with apremilast during routine dermatology care in Germany
Reich, K.
Fritzlar, S.
Korge, B.
Manasterski, M.
Schwichtenberg, U.
Morys, S.
Lampl, M.
Roemmler-Zehrer, J.
Gomez, Nunez N.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 123 - 123
[3] PHYSICIAN- AND PATIENT-REPORTED OUTCOMES WITH APREMILAST FOR PATIENTS WITH PLAQUE PSORIASIS DURING ROUTINE DERMATOLOGY CARE IN GERMANY: A SECOND INTERIM ANALYSIS
Reich, Kristian
Bomas, Stefanie
Korge, Bernhard
Schwichtenberg, Uwe
Mentz, Hannah
Groegel, Kathrin
Gomez, Natalie Nunez
ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 13 - 13
[4] Physician- and patient-reported outcomes with apremilast for patients with plaque psoriasis during routine dermatology care in Germany: A second interim analysis
Reich, Kristian
Bomas, Stefanie
Korge, Bernhard
Manasterski, Maria
Schwichtenberg, Uwe
Mentz, Hannah
Groegel, Kathrin
Gomez, Natalie Nune
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB221 - AB221
[5] Patient- and physician-reported outcomes with apremilast for patients with plaque psoriasis during routine dermatology care in Germany: an interim analysis
Reich, K.
Bomas, S.
Korge, B.
Manasterski, M.
Schwichtenberg, U.
Mentz, H.
Groegel, K.
Gomez, N. Nunez
BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E257 - E257
[6] Effect of apremilast on patient-reported outcomes in patients with moderate to severe plaque psoriasis in the ESTEEM 1 trial
Armstrong, April
Griffiths, Christopher
Tencer, Tom
Li, Stan
Zhang, Frank
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB231 - AB231
[7] Effect of apremilast on patient-reported outcomes in patients with moderate to severe plaque psoriasis in the ESTEEM 1 trial
Armstrong, A. W.
Griffiths, C.
Tencer, T.
Li, S.
Zhang, F.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 67 - 67
[8] Evaluation of Patient-Reported Outcomes With Etanercept in Moderate to Severe Plaque Psoriasis Patients After Therapy With Apremilast
Bagel, Jerry
Stolshek, Bradley S.
Yang, Yue
Kricorian, Gregory
Kircik, Leon H.
JOURNAL OF DRUGS IN DERMATOLOGY, 2020, 19 (04) : 378 - 383
[9] Changes in patient-reported outcomes with etanercept treatment following apremilast failure in patients with moderate to severe psoriasis
Bagel, Jerry
Stolshek, Bradley S.
Samad, Ahmed S.
Yang, Yue
Chung, James B.
Kricorian, Gregory
Kircik, Leon
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB180 - AB180
[10] Real-world dermatology visit in moderate to severe plaque psoriasis patients treated with biologics or apremilast
Wu, Jashin J.
Zhang, Jingchuan
Zhao, Yang
Martinez, Diane
Lopez-Gonzalez, Lorena
Marchlewicz, Elizabeth H.
Shrady, George
Mendelsohn, Alan
Feldman, Steven
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB80 - AB80

← 1 2 3 4 5 →